Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28245652 | 1.00 | CHRM2 (0.31) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL29252657 | 0.79 | KCNH2 (0.37) | ACHEKCNH2 | |
| SCHEMBL18612376 | 0.76 | RNPEP (0.32) | — | |
| Iodide SCHEMBL7512251 | 0.74 | — | — | |
| SCHEMBL27656272 | 0.74 | CHRM2 (0.43) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Bromide SCHEMBL28065828 | 0.72 | RAD52 (0.45) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| Hydrochloric Acid SCHEMBL28065870 | 0.72 | KMT2A (0.45) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL2563316 | 0.72 | CHRM2 (0.47) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL1168955 | 0.72 | CHRM2 (0.47) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL27656267 | 0.72 | CHRM2 (0.47) | CHRM2ADRA2AADORA3CHRM1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8197716-B2 | Electromagnetic-wave suppressing material, electromagnetic-wave suppressing device, and electronic apparatus | SONY CORPORATION (JP) | 2012-06-12 | — | — | US | claimed |
| US-20260140407-A1 | ELECTROCHROMIC SHEET AND ELECTROCHROMIC DEVICE | SUMITOMO BAKELITE CO., LTD. (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250208475-A1 | ELECTROCHROMIC SHEET, LENS FOR EYEGLASSES, AND EYEGLASSES | SUMITOMO BAKELITE CO., LTD. (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-120153314-A | Electrochromic sheet and electrochromic device | 住友电木株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-116829652-B | Liquid composition set, porous resin production device, and porous resin production method | 株式会社理光 | 2025-05-27 | — | — | CN | disclosed |
| CN-119998720-A | Electrochromic sheet, laminate, lens for spectacles, and spectacles | 住友电木株式会社 | 2025-05-13 | — | — | CN | disclosed |
| EP-4535485-A1 | LITHIUM-BASED SOLID ELECTROLYTE, METHOD FOR PRODUCING LITHIUM-BASED SOLID ELECTROLYTE, MODIFIED POSITIVE ELECTRODE ACTIVE MATERIAL, MODIFIED NEGATIVE ELECTRODE ACTIVE MATERIAL, ALL-SOLID-STATE SECONDARY BATTERY, ELECTRODE SHEET FOR ALL-SOLID-STATE SECONDARY BATTERIES, SOLID ELECTROLYTE SHEET, AND ELECTRODE FOR ALL-SOLID-STATE SECONDARY BATTERIES | FUJIFILM Corporation (JP) | 2025-04-09 | — | — | EP | disclosed |
| CN-119278527-A | Lithium-based solid electrolyte, method for producing lithium-based solid electrolyte, modified positive electrode active material, modified negative electrode active material, all-solid secondary battery, electrode sheet for all-solid secondary battery, solid electrolyte sheet, and electrode for all-solid secondary battery | 富士胶片株式会社 | 2025-01-07 | — | — | CN | disclosed |
| CN-118984969-A | Electrochromic sheet, eyeglass lens and eyeglass | 住友电木株式会社 | 2024-11-19 | — | — | CN | disclosed |
| CN-101142643-B | Electrochemical cell | SEIKO INSTR INC | 2011-06-22 | — | — | CN | disclosed |
| EP-1921125-B1 | Reversible recording material and displaying element | RICOH CO LTD (JP) | 2011-04-27 | — | — | EP | disclosed |
| US-20090175021-A1 | Electromagnetic-wave suppressing material, electromagnetic-wave suppressing device, and electronic apparatus | SONY CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090011330-A1 | Electrochemical Cell | SII MICRO PARTS LTD. (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1921125-A2 | Reversible recording material and displaying element | Ricoh Company, Ltd. (JP) | 2008-05-14 | — | — | EP | disclosed |
| CN-101142643-A | Electrochemical cell | SII MICRO PARTS LTD (JP) | 2008-03-12 | — | — | CN | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
| US-20060088767-A1 | Battery with molten salt electrolyte and high voltage positive active material | TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC. | 2006-04-27 | — | — | US | disclosed |
| WO-2006026773-A2 | BATTERY WITH MOLTEN SALT ELECTROLYTE AND HIGH VOLTAGE POSITIVE ACTIVE MATERIAL | TOYOTA TECHNICAL CENTER USA, INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| WO-2000037400-A1 | HALOGENATION IN IONIC LIQUIDS | INEOS CHLOR LIMITED (GB) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | MYOC, MB, MYOF | CHRM2 433/4885ADRA2A 4412/4885ADORA3 3226/4885 |
| US-20260140407-A1 | ELECTROCHROMIC SHEET AND ELECTROCHROMIC DEVICE | GJB2, LNPK, KCNN2 | CHRM2 2596/4885ADRA2A 4488/4885ADORA3 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.